-+ 0.00%
-+ 0.00%
-+ 0.00%

CRINETICS ANNOUNCES STRONG PALSONIFY LAUNCH EXECUTION AND POSITIVE RESULTS FOR CONCURRENT ANDROSTENEDIONE LOWERING AND GLUCOCORTICOID DOSE REDUCTION IN PHASE 2 TRIAL OF ATUMELNANT FOR CONGENITAL ADRENAL HYPERPLASIA

Reuters·01/05/2026 13:00:07

Please log in to view news